Mundipharma is Promoting ActiPatch US expert pr
Post# of 7813
(Total Views: 309)
Posted On: 03/14/2019 9:45:13 AM
Mundipharma is Promoting ActiPatch
US expert presents evidence for innovative drug-free pain management device, ActiPatch®
Mundipharma was pleased to welcome Biomedical Engineer Dr Sree Koneru
to Australia to give a presentation on the innovative pain management device, ActiPatch®, which he helped develop.
ActiPatch® uses electromagnetic pulse therapy to provide long-lasting pain relief.Dr Koneru is the Vice President of Product Development for Bioelectronics and visited Australia to present the clinical evidence behind ActiPatch® at the Australian Pharmacy Conference on the Gold Coast.
You can watch Dr Koneru discussing ActiPatch® on Chanel Seven’s Weekend Sunrise here.
“The new understanding of chronic pain is that nerves ‘memorise’ the initial pain from injury and over time, become hyperreactive,” Dr Koneru said. “When used over a painful area, ActiPatch’s pulsed signal is absorbed by tissue and disrupts hyperactivity of the nerves,
resulting in lasting relief.”
Electromagnetic pulse therapy helps to relieve pain from mild osteoarthritis and general musculoskeletal pain in the back, knee, heel and other muscle joints. It is also ideal for strains, sprains and other painful conditions. The therapy is completely sensation free, with
no heat, tingling sensations or vibration. ActiPatch® is drug-free and can be safely used with any other medications.
A registry study of more than 5,000 chronic pain sufferers using ActiPatch® indicated that:
• More than 65% per cent reported a clinically meaningful reduction in pain from a widevariety of causes and locations of pain
• The average pain reduction reported in these individuals was 57%
• The 3-month follow-up showed sustained pain relief, decreased oral analgesicmedication use and quality of life improvement.
https://prwire.com.au/pr/82565/us-expert-pres...ctipatch-r
https://vimeo.com/323324118
US expert presents evidence for innovative drug-free pain management device, ActiPatch®
Mundipharma was pleased to welcome Biomedical Engineer Dr Sree Koneru
to Australia to give a presentation on the innovative pain management device, ActiPatch®, which he helped develop.
ActiPatch® uses electromagnetic pulse therapy to provide long-lasting pain relief.Dr Koneru is the Vice President of Product Development for Bioelectronics and visited Australia to present the clinical evidence behind ActiPatch® at the Australian Pharmacy Conference on the Gold Coast.
You can watch Dr Koneru discussing ActiPatch® on Chanel Seven’s Weekend Sunrise here.
“The new understanding of chronic pain is that nerves ‘memorise’ the initial pain from injury and over time, become hyperreactive,” Dr Koneru said. “When used over a painful area, ActiPatch’s pulsed signal is absorbed by tissue and disrupts hyperactivity of the nerves,
resulting in lasting relief.”
Electromagnetic pulse therapy helps to relieve pain from mild osteoarthritis and general musculoskeletal pain in the back, knee, heel and other muscle joints. It is also ideal for strains, sprains and other painful conditions. The therapy is completely sensation free, with
no heat, tingling sensations or vibration. ActiPatch® is drug-free and can be safely used with any other medications.
A registry study of more than 5,000 chronic pain sufferers using ActiPatch® indicated that:
• More than 65% per cent reported a clinically meaningful reduction in pain from a widevariety of causes and locations of pain
• The average pain reduction reported in these individuals was 57%
• The 3-month follow-up showed sustained pain relief, decreased oral analgesicmedication use and quality of life improvement.
https://prwire.com.au/pr/82565/us-expert-pres...ctipatch-r
https://vimeo.com/323324118
(2)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼